AzTrials
AzTrials

Postoperative Cognitive Dysfunction (POCD)NCT07701187

Intravenous Anesthesıa and Cognıtıve Functıon ın Spınal Surgery

A study of Postoperative Cognitive Dysfunction (POCD), run by Bursa Yuksek Ihtisas Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the effect of these two different intravenous infusion techniques [manuel controlled infusion (MCI) and Target controlled Infusion( TCI)] on POCD. To assess POCD, the Mini Mental State Examination (MMSE ) and the Montreal Cognitive Assessment (MoCA ) will be used. Read more about this study

Who is it for?
Ages 18 to 65 years
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 Sep 2023to 22 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Turkish language proficiency,
  • age (18-65 years),
  • American Society of Anesthesiologists (ASA) I-III score,
  • elective spinal surgery.

Who cannot join

  • - refusal to participate
  • central nervous system disorders,
  • use of antidepressants or antipsychotic medications,
  • alcohol or drug use,
  • illiteracy.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bursa yüksek ihtisas eğitim ve araştırma hastanesi BURSA, Bursa, Türkiye, BURSA, Bursa 16310, BURSA, Bursa

    Bursa, Bursa, 16310

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Two Dıfferent Intravenous Anesthesıa Technıques on Cognıtıve Functıons ın Spınal Surgery

The aim of this study is to investigate the effect of these two different intravenous infusion techniques [manuel controlled infusion (MCI) and Target controlled Infusion( TCI)] on POCD. To assess POCD, the Mini Mental State Examination (MMSE ) and the Montreal Cognitive Assessment (MoCA ) will be used. MoCA and MMSE have high sensitivity and specificity for identifying patients with mild cognitive impairment who perform within the normal range. In a study by Meng et al., comparing target-controlled infusion and manual infusion of propofol anesthesia during electroconvulsive therapy, the randomized, controlled trial showed no significant difference in postelectroconvulsive therapy changes in MoCA scores in either group; however, they reported improvement in MoCA scores after 6 electroconvulsive therapy treatments in the MCI group, while deterioration occurred in the TCI group. Researchers found no studies investigating the effects of both infusion methods in spinal surgery and their impact on cognitive function, and they planned to evaluate the effects of the groups in their study.

Being tested
Manual Controlled Infusion (MCI) of Propofol, Target Controlled Infusion (TCI) of Propofol
Keywords
target-controlled infusion, Manuel-controlled infüsion, propofol, Post-Operative Cognitive Dysfunction
Medical subject headings
Postoperative Cognitive Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manual Controlled Infusion (MCI) of PropofolDrug

    Propofol infusion initiated at 10 mg/kg/h and decreased to 9 and 6 mg/kg/h at 10-minute intervals, combined with remifentanil (0.5-1 μg/kg/min) titrated to maintain a BIS score of 40-60.

  • Target Controlled Infusion (TCI) of PropofolDrug

    Propofol infused via a TCI device using the Eleveld PK/PD model with an initial target plasma concentration of 2.5-4 μg/mL, combined with remifentanil (0.5-1 μg/kg/min) titrated to maintain a BIS score of 40-60.

Study groups in NCT07701187
Study groupRoleWhat they receive
MCI GroupActive comparatorManual Controlled Infusion (MCI) group. Anesthesia induced with propofol, rocuronium, and fentanyl. Maintenance achieved with propofol infusion initiated at 10 mg/kg/h and adjusted at 10-minute intervals (9 and 6 mg/kg/h) alongside remifentanil, titrated to maintain a BIS score of 40-60.
Receives: Drug: Manual Controlled Infusion (MCI) of Propofol
TCI GroupExperimentalTarget Controlled Infusion (TCI) group. Anesthesia induced with propofol, rocuronium, and fentanyl. Maintenance achieved with propofol infused via a TCI device using the Eleveld PK/PD model with a target plasma concentration of 2.5-4 μg/mL alongside remifentanil, titrated to maintain a BIS score of 40-60.
Receives: Drug: Target Controlled Infusion (TCI) of Propofol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Early Postoperative Cognitive Functions Evaluated by the Mini-Mental State Examination

    The MMSE is a 30-point questionnaire used to measure cognitive impairment. Scores range from 0 to 30, with higher scores indicating better cognitive function. Postoperative cognitive dysfunction (POCD) is defined as a decrease of at least 1 to 2 points on the MMSE score at the 24th postoperative hour compared to the preoperative baseline values.

    Measured: Preoperatively (baseline) and 24 hours postoperatively.

  2. Early Postoperative Cognitive Functions Evaluated by the Montreal Cognitive Assessment

    The MoCA is a 30-point screening tool for detecting mild cognitive impairment. Scores range from 0 to 30, with higher scores indicating better cognitive function. A score of 26 or higher is considered normal. Postoperative cognitive dysfunction (POCD) is defined as a decrease of at least 1 to 2 points on the MoCA score at the 24th postoperative hour compared to the preoperative baseline values.

    Measured: Preoperatively (baseline) and 24 hours postoperatively.

Secondary outcomes (8)
  1. Total Intraoperative Propofol Consumption

    The total amount of propofol administered throughout the anesthesia duration, measured in milligrams (mg).

    Measured: From the initiation of anesthesia induction until the cessation of anesthetic drug infusion at the end of the surgical procedure (assessed at the end of surgery, up to 5 hours).

  2. Total Intraoperative Remifentanil Consumption

    The total amount of remifentanil administered throughout the anesthesia duration, measured in micrograms (μg).

    Measured: From the initiation of anesthesia induction until the cessation of anesthetic drug infusion at the end of the surgical procedure (assessed at the end of surgery, up to 5 hours).

  3. Intraoperative Heart Rate (HR)

    Evaluation of heart rate measured in beats per minute (bpm) to assess intraoperative hemodynamic stability.

    Measured: Intraoperatively at 5, 10, and 15 minutes after induction, and every 30 minutes thereafter until the end of surgery.

  4. Intraoperative Mean Arterial Pressure (MAP)

    Evaluation of mean arterial pressure measured in millimeters of mercury (mmHg) to assess intraoperative hemodynamic stability.

    Measured: Intraoperatively at 5, 10, and 15 minutes after induction, and every 30 minutes thereafter until the end of surgery.

  5. Bispectral Index (BIS) Scores

    Continuous monitoring of anesthetic depth using BIS index values (ranging from 0 to 100, where 40-60 indicates adequate general anesthesia).

    Intraoperatively at 5, 10, and 15 minutes after induction, and every 30 minutes thereafter until the end of surgery.

    Measured: Intraoperatively at 5, 10, and 15 minutes after induction, and every 30 minutes thereafter until the end of surgery.

  6. Intraoperative Oxygen Saturation (SpO2)

    Continuous monitoring of peripheral oxygen saturation percentage (%).

    Measured: Intraoperatively from induction until the end of surgery.

  7. Postoperative Recovery Time

    The duration (in minutes) from the cessation of anesthetic drug infusion until the patient achieves adequate recovery criteria (Aldrete score ≥ 9 or institutional criteria) for transfer.

    Measured: From the time of anesthetic drug cessation (extubation) up to discharge from the operating room / recovery unit (typically assessed up to 60 minutes)

  8. Longitudinal Cognitive Change Scores (Delta)

    The calculation of net change scores (Δ) for both MMSE and MoCA, determined by subtracting the preoperative baseline score from the 24-hour postoperative score.

    Measured: Calculated at 24 hours postoperatively using baseline data.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study start22 Sep 2023
  3. Primary completion22 Sep 2024
  4. Study completion22 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a prospective, randomized controlled, single-blind, parallel-group clinical trial designed to compare target-controlled infusion (TCI) and manual-controlled infusion (MCI) of propofol anesthesia in elective spine surgery. Patients are allocated in a 1:1 ratio to receive either MCI (Group 1) or TCI (Group 2) for anesthesia maintenance, with the primary objective of evaluating their respective impacts on early postoperative cognitive functions
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
128 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07701187
Sponsor's protocol ID
2011-KAEK-25 2023/09-09
Status last verified
Oct 2026
First submitted
29 Jun 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bayburt NS, Duruk Erkent FN, Guven A, Alkis N. Comparison of the Effects of Target-Controlled Versus Conventional Infusion Sedation on Recovery in Geriatric Patients Undergoing Diagnostic Cystoscopy. Turk J Anaesthesiol Reanim. 2026 Feb 9;54(1):40-48. doi: 10.4274/TJAR.2025.252107. Epub 2025 Oct 1.

    PubMed 40916451

Questions about this trial

What is this clinical trial studying?

A study of Postoperative Cognitive Dysfunction (POCD), run by Bursa Yuksek Ihtisas Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Early Postoperative Cognitive Functions Evaluated by the Mini-Mental State Examination (time frame: Preoperatively (baseline) and 24 hours postoperatively.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07701187, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in